Company / Working Capital
Citius Pharmaceuticals, Inc. Working Capital History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$14.7K
FY2013
5-year range
-$45.8K / -$14.7K
FY2011-FY2013
Trend
+67.9%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$23,841 to -$14,694 over the past 2 years.
Based on SEC 10-K filings.
-$14,694 in FY2013.
Improved from -$23,841 to -$14,694 over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, working capital increased 67.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | -$14.7K | +67.9% |
| FY2012 | -$45.8K | -92.3% |
| FY2011 | -$23.8K | - |
As of FY2013 · SEC 10-K · Updated Jun 22, 2026